Patents and drug insurance: Clash of the Titans?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Patents and drug insurance: Clash of the Titans?

Published:2018-11-14 Issue:467 Volume:10 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Phelps Charles^ORCID,Madhavan Guruprasad^ORCID

Abstract

The confluence of patent law and drug insurance creates a unique challenge for patients in the United States and could affect future biomedical R&D.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference6 articles.

1. N. Augustine G. Madhavan S. Nass Eds. Making Medicines Affordable: A National Imperative (The National Academies Press 2018).

2. M. Chernew J. Newhouse Health care spending growth in Handbook of Health Economics M. V. Pauly T. G. McGuire P. P. Barros Eds. (Elsevier 2012) vol. 2.

3. P. M. Danzon Economics of the pharmaceutical industry (NBER Reporter Online National Bureau of Economic Research 2006) pp. 14–17.

4. Insurance and Incentives for Medical Innovation

5. The Council of Economic Advisers Reforming Biopharmaceutical Pricing at Home and Abroad (CEA Executive Office of the President of the United States 2018).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extending Exclusivity for Biopharmaceuticals to Deter Competing Generics: A Review of Strategies, Potential Mitigation, and Similarities to Infringement;Technology & Innovation;2020-08-29

2. Valuing Health: Evolution, Revolution, Resistance, and Reform;Value in Health;2019-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP